Flaxseed powder and cardiovascular risk factor

Phase 2

• Conditions: Condition 1: Hypertention. Condition 2: Dyslipidemia.; ???? ??? ???? ??????? ??? (??????) (??? ???) (?????) (?????) (?????) (???????); ????????????? ????????

• Registration Number: IRCT2016081611763N28
• Lead Sponsor: Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Triglyceride concentrations more than 150; Total cholesterol levels more than 200; LDL-C levels more than 130; HDL-C levels less than 40 mg per dl; blood pressure equal to or more than 140/90 mmHg.
Exclusion criteria: Pregnancy ; Breast-feeding; being on a diet during the last three month; renal disease; cancer; Fasting blood sugar more than 110; infection and inflammatory diseases

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cholestrol. Timepoint: At the first and end of study. Method of measurement: laboratory.;HDL-C. Timepoint: At the first and end of study. Method of measurement: laboratory.;TG. Timepoint: AT THE FIRST AND THE END OF STUDY. Method of measurement: Laboratory measurements.;LDL-C. Timepoint: AT THE FIRST AND THE END OF STUDY. Method of measurement: Laboratory measurements.;Blood pressure. Timepoint: first middle end of the study. Method of measurement: pressure indicator.;Crp. Timepoint: first and end of the study. Method of measurement: Laboratory measurements.;Weight. Timepoint: First,middle and the end of study. Method of measurement: scale.